Clinical trial
Retrospective Study to Evaluate Efficacy and Safety of Trabectedin (Yondelis®) in Sarcoma Patients
NCT03284320 is registered in ClinicalTrials.gov with University Medicine Greifswald as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Retrospective Study to Evaluate Efficacy and Safety of Trabectedin (Yondelis®) in Sarcoma Patients
- Lead sponsor
- University Medicine Greifswald
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 18, 2017
- Completion date
- November 1, 2021
- Enrollment
- 514 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
sarcoma of bone, sarcoma of soft tissue